SIGA (SIGA) Q2 2025 Earnings Call August 05, 2025 04:30 PM ET Speaker0Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties that could cause actual results to differ from the forward looking statements. SIGA does not undertake any obligation to update publicly any forward looking statements to ref ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2025 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ________ to ___________ Commission File No. 0-23047 SIGA Technologies, Inc. Delaware 13-3864870 (State or other jurisdiction of incorporation ...

Exhibit 99.1 (1) Includes supportive services related to product sales. Key Business and Operational Activity: "In the second quarter, we achieved two positive milestones: significant product revenues and expanded development funding under the BARDA 19C contract," stated Diem Nguyen, Chief Executive Officer. "Specifically, in the second quarter, we recorded approximately $53 million of oral TPOXX sales and $26 million of IV TPOXX sales in connection with deliveries to the Strategic National Stockpile. Addit ...

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor ...

Siga Technologies Inc. (SIGA) ended the recent trading session at $7.06, demonstrating a -1.4% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 0.07%. On the other hand, the Dow registered a loss of 0.7%, and the technology-centric Nasdaq increased by 0.18%. The stock of company has risen by 11.18% in the past month, leading the Medical sector's gain of 2.39% and the S&P 500's gain of 5.71%.The investment community will be paying close attention t ...

Company Overview A Leader in Global Health & Infectious Diseases 1 Forward Looking Statements 2 Contents Introduction 1 The Smallpox Threat 2 TPOXX®: A Differentiated Product 3 Financial Summary 4 SIGA at a Glance Stellar Revenue Generation >$1bn of Procurement Contracts from 10+ years Working with Governments 30+ Countries Where Products Have Been Sold We are dedicated to advancing our strategic initiatives, driving shareholder value, and enhancing national health security as we deliver TPOXX to U.S. and g ...

Company Performance - Siga Technologies Inc. (SIGA) closed at $6.12, reflecting a -4.67% change from the previous day's closing price, underperforming the S&P 500's daily loss of 0.22% [1] - The company's stock gained 9.93% over the previous month, outperforming the Medical sector, which had a loss of 0%, and the S&P 500, which gained 0.45% [1] Earnings Projections - For the full year, Zacks Consensus Estimates project earnings of $0.13 per share and revenue of $184.36 million, representing changes of -84.15% and +32.97% from the prior year, respectively [2] Analyst Forecasts - Recent revisions to analyst forecasts for Siga Technologies Inc. should be monitored, as they reflect short-term business trends and can indicate analyst optimism regarding the company's profitability [3] Valuation Metrics - Siga Technologies Inc. has a Forward P/E ratio of 49.38, indicating a premium compared to its industry's Forward P/E of 16.85 [6] - The Medical - Drugs industry, part of the Medical sector, currently holds a Zacks Industry Rank of 77, placing it in the top 32% of over 250 industries [6] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown a proven track record of outperformance, with 1 stocks returning an average of +25% annually since 1988 [5] - Currently, Siga Technologies Inc. holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate remaining stagnant over the past month [5]

Siga Technologies Inc. (SIGA) ended the recent trading session at $6.36, demonstrating a -1.24% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 1.13%. Meanwhile, the Dow experienced a drop of 1.79%, and the technology-dominated Nasdaq saw a decrease of 1.3%. Shares of the company have appreciated by 8.78% over the course of the past month, outperforming the Medical sector's gain of 3.07%, and the S&P 500's gain of 3.55%.The upcoming earnings releas ...

SIGA (SIGA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Diem Nguyen - CEO & DirectorDaniel Luckshire - EVP & CFOJyoti Prakash - Director Operator Good afternoon. Welcome to FIGA Technology Business Update Call. Before we turn the call over to FIGA management, please note that any forward looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties that could cause actual results to differ from the ...

SIGA (SIGA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good afternoon. Welcome to FIGA Technology Business Update Call. Before we turn the call over to FIGA management, please note that any forward looking statements made during this call are based on management's current expectations and observations and are subject to risks and uncertainties that could cause actual results to differ from the forward looking statements. SIGA does not undertake any obligation to update publicly any forward look ...